Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash & Current Investments (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Cash & Current Investments for 7 consecutive years, with $775.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 75.9% to $775.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $775.3 million through Dec 2025, up 75.9% year-over-year, with the annual reading at $775.3 million for FY2025, 75.9% up from the prior year.
  • Cash & Current Investments hit $775.3 million in Q4 2025 for Harmony Biosciences Holdings, up from $672.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $775.3 million in Q4 2025 to a low of $141.2 million in Q1 2021.
  • Historically, Cash & Current Investments has averaged $366.4 million across 5 years, with a median of $362.1 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: tumbled 31.43% in 2021 and later soared 133.58% in 2022.
  • Year by year, Cash & Current Investments stood at $156.8 million in 2021, then skyrocketed by 133.58% to $366.2 million in 2022, then fell by 3.48% to $353.5 million in 2023, then rose by 24.71% to $440.8 million in 2024, then skyrocketed by 75.9% to $775.3 million in 2025.
  • Business Quant data shows Cash & Current Investments for HRMY at $775.3 million in Q4 2025, $672.6 million in Q3 2025, and $446.9 million in Q2 2025.